当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-12-21 , DOI: 10.1056/nejmoa2212419 Rona Yaeger 1 , Jared Weiss 1 , Meredith S Pelster 1 , Alexander I Spira 1 , Minal Barve 1 , Sai-Hong I Ou 1 , Ticiana A Leal 1 , Tanios S Bekaii-Saab 1 , Cloud P Paweletz 1 , Grace A Heavey 1 , James G Christensen 1 , Karen Velastegui 1 , Thian Kheoh 1 , Hirak Der-Torossian 1 , Samuel J Klempner 1
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2022-12-21 , DOI: 10.1056/nejmoa2212419 Rona Yaeger 1 , Jared Weiss 1 , Meredith S Pelster 1 , Alexander I Spira 1 , Minal Barve 1 , Sai-Hong I Ou 1 , Ticiana A Leal 1 , Tanios S Bekaii-Saab 1 , Cloud P Paweletz 1 , Grace A Heavey 1 , James G Christensen 1 , Karen Velastegui 1 , Thian Kheoh 1 , Hirak Der-Torossian 1 , Samuel J Klempner 1
Affiliation
New England Journal of Medicine, Ahead of Print.
中文翻译：
阿达格拉西联合或不联合西妥昔单抗治疗 KRAS G12C 突变的结直肠癌
新英格兰医学杂志，印刷前。
更新日期：2022-12-22
中文翻译：
阿达格拉西联合或不联合西妥昔单抗治疗 KRAS G12C 突变的结直肠癌
新英格兰医学杂志，印刷前。
京公网安备 11010802027423号